[Absence of cutaneous complications following extravasation of pegylated liposomal doxorubicin]

Presse Med. 2003 Jun 28;32(23):1077.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects*
  • Drug Eruptions / therapy*
  • Edema / chemically induced
  • Edema / therapy
  • Erythema / chemically induced
  • Erythema / therapy
  • Extravasation of Diagnostic and Therapeutic Materials / complications*
  • Female
  • Follow-Up Studies
  • Humans
  • Liposomes
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Ovarian Neoplasms / drug therapy*
  • Polyethylene Glycols / administration & dosage
  • Polyethylene Glycols / adverse effects*

Substances

  • Liposomes
  • Polyethylene Glycols
  • Doxorubicin